Fastigial nuclei surgical damage and focal midbrain disruption implicate PAG survival circuits in cerebellar mutism syndrome.
cerebellar mutism syndrome
fastigial nuclei
medulloblastoma
periaqueductal gray
posterior fossa syndrome
Journal
Neuro-oncology
ISSN: 1523-5866
Titre abrégé: Neuro Oncol
Pays: England
ID NLM: 100887420
Informations de publication
Date de publication:
14 02 2023
14 02 2023
Historique:
pubmed:
6
7
2022
medline:
16
2
2023
entrez:
5
7
2022
Statut:
ppublish
Résumé
Pediatric postoperative cerebellar mutism syndrome (CMS) is a rare but well-known complication of medulloblastoma (Mb) resection with devastating effects on expressive language, mobility, cognition, and emotional regulation that diminishes quality of life for many Mb survivors. The specific anatomical and neuronal basis of CMS remains obscure. We address this issue by identifying patterns of surgical damage and secondary axonal degeneration in Mb survivors with CMS. Children with Mb deemed high risk for CMS based on intraventricular location of the tumor had T1 images analyzed for location(s) of surgical damage using a specially developed algorithm. We used three complementary methods of spatial analysis to identify surgical damage linked to CMS diagnosis. Magnetization transfer ratio (MTR) images were analyzed for evidence of demyelination in anatomic regions downstream of the cerebellum, indicating neuronal dysfunction. Spatial analyses highlighted damage to the fastigial nuclei and their associated cerebellar cortices as the strongest predictors of CMS. CMS-related MTR decrease was greatest in the ventral periaqueductal gray (PAG) area and highly consistent in the left red nucleus. Our evidence points to disruption of output from the fastigial nuclei as a likely causal trigger for CMS. We propose that core CMS symptoms result from a disruption in the triggering of survival behaviors regulated by the PAG, including the gating of vocalization and volitional movement. The fastigial nuclei provide the densest output to the PAG from the cerebellum, thus sparing these structures may provide a greater likelihood of CMS prevention.
Sections du résumé
BACKGROUND
Pediatric postoperative cerebellar mutism syndrome (CMS) is a rare but well-known complication of medulloblastoma (Mb) resection with devastating effects on expressive language, mobility, cognition, and emotional regulation that diminishes quality of life for many Mb survivors. The specific anatomical and neuronal basis of CMS remains obscure. We address this issue by identifying patterns of surgical damage and secondary axonal degeneration in Mb survivors with CMS.
METHODS
Children with Mb deemed high risk for CMS based on intraventricular location of the tumor had T1 images analyzed for location(s) of surgical damage using a specially developed algorithm. We used three complementary methods of spatial analysis to identify surgical damage linked to CMS diagnosis. Magnetization transfer ratio (MTR) images were analyzed for evidence of demyelination in anatomic regions downstream of the cerebellum, indicating neuronal dysfunction.
RESULTS
Spatial analyses highlighted damage to the fastigial nuclei and their associated cerebellar cortices as the strongest predictors of CMS. CMS-related MTR decrease was greatest in the ventral periaqueductal gray (PAG) area and highly consistent in the left red nucleus.
CONCLUSION
Our evidence points to disruption of output from the fastigial nuclei as a likely causal trigger for CMS. We propose that core CMS symptoms result from a disruption in the triggering of survival behaviors regulated by the PAG, including the gating of vocalization and volitional movement. The fastigial nuclei provide the densest output to the PAG from the cerebellum, thus sparing these structures may provide a greater likelihood of CMS prevention.
Identifiants
pubmed: 35789275
pii: 6628827
doi: 10.1093/neuonc/noac168
pmc: PMC9925705
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
375-385Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Elife. 2020 Jul 08;9:
pubmed: 32639229
Cortex. 2010 Jul-Aug;46(7):831-44
pubmed: 20152963
Childs Nerv Syst. 2020 Jun;36(6):1171-1179
pubmed: 31273496
Front Syst Neurosci. 2022 Jan 11;15:781527
pubmed: 35087384
Handb Clin Neurol. 2018;155:273-288
pubmed: 29891065
Childs Nerv Syst. 2020 Jun;36(6):1145-1151
pubmed: 31177321
Quant Imaging Med Surg. 2016 Oct;6(5):535-544
pubmed: 27942473
J Physiol. 2017 Jul 1;595(13):4151-4158
pubmed: 28294351
J Neurol Neurosurg Psychiatry. 2005 Feb;76(2):266-8
pubmed: 15654048
J Neurophysiol. 1994 Sep;72(3):1337-56
pubmed: 7807216
Cerebellum. 2020 Feb;19(1):102-125
pubmed: 31522332
Front Neural Circuits. 2013 Apr 23;7:72
pubmed: 23630468
J Neurosci. 2015 Oct 21;35(42):14132-47
pubmed: 26490855
Neurosci Lett. 2019 Jan 1;688:62-75
pubmed: 29997061
Nat Commun. 2020 Oct 15;11(1):5207
pubmed: 33060630
Neuron. 2019 Aug 7;103(3):459-472.e4
pubmed: 31204083
Pediatr Neurosurg. 1999 Sep;31(3):131-6
pubmed: 10708354
Brain Struct Funct. 2019 Jul;224(6):2153-2165
pubmed: 31165919
Neuro Oncol. 2021 Sep 1;23(9):1586-1596
pubmed: 33823018
Data Brief. 2015 Jul 31;4:577-82
pubmed: 26322322
Lancet Child Adolesc Health. 2021 Nov;5(11):814-824
pubmed: 34624241
J Physiol. 2014 May 15;592(10):2197-213
pubmed: 24639484
AJNR Am J Neuroradiol. 2000 Jun-Jul;21(6):1073-7
pubmed: 10871017
Neuroimage. 2012 Jul 16;61(4):1213-25
pubmed: 22525876
Trans Am Neurol Assoc. 1961;86:245-6
pubmed: 13913742
Neuroreport. 1999 Mar 17;10(4):681-5
pubmed: 10208530
J Neurosurg Pediatr. 2008 Mar;1(3):262
pubmed: 18352776
Childs Nerv Syst. 2016 Jul;32(7):1195-203
pubmed: 27142103
Neurology. 2019 Oct 15;93(16):e1561-e1571
pubmed: 31527284
Neuroimage. 2012 Jul 16;61(4):805-11
pubmed: 22465459
Childs Nerv Syst. 2020 Jun;36(6):1215-1222
pubmed: 31222445
Brain Struct Funct. 2019 Jun;224(5):1739-1751
pubmed: 30980139
AJNR Am J Neuroradiol. 2014 Apr;35(4):797-802
pubmed: 24184519
Neuroimage. 2006 Oct 15;33(1):127-38
pubmed: 16904911
Neuroimage. 2018 May 15;172:437-449
pubmed: 29408539
Neurology. 1959 Oct;9:636-42
pubmed: 13791737
Elife. 2020 Dec 29;9:
pubmed: 33372655
J Comp Neurol. 2016 Jun 1;524(8):1558-77
pubmed: 26355872
Elife. 2020 Mar 24;9:
pubmed: 32207681